P. Chin

发表

t(8;21) Acute Myeloid Leukemia as a Paradigm for the Understanding of Leukemogenesis at the Level of Gene Regulation and Chromatin Programming

C. Bonifer, O. Heidenreich, F. Barneh, 2020, Cells.

Identification and interrogation of the gene regulatory network of CEBPA-double mutant acute myeloid leukemia

Salam A. Assi, C. Bonifer, P. Cockerill, 2022, Leukemia.

The Oncogenic Transcription Factor RUNX1/ETO Corrupts Cell Cycle Regulation to Drive Leukemic Transformation

Salam A. Assi, J. Allan, C. Bonifer, 2018, Cancer cell.

Isoform-specific and signaling-dependent propagation of acute myeloid leukemia by Wilms tumor 1.

Salam A. Assi, S. Moriya, N. Seki, 2021, Cell reports.

Subtype-specific regulatory network rewiring in acute myeloid leukemia

Salam A. Assi, P. Cauchy, L. N. Gilding, 2018, Nature Genetics.

University of Birmingham Subtype-specific regulatory network rewiring in acute myeloid leukemia

Salam A. Assi, L. N. Gilding, C. Bonifer, 2018 .

Modelling t(8;21) acute myeloid leukaemia ‐ What have we learned?

C. Bonifer, P. S. Chin, P. Chin, 2020, MedComm.

RUNX1-ETO Depletion in t(8;21) AML Leads to C/EBPα- and AP-1-Mediated Alterations in Enhancer-Promoter Interaction

Cameron S. Osborne, Salam A. Assi, C. Osborne, 2019, Cell reports.

The Oncogenic Transcript ion Factor RUNX 1 / ETO Corrupts Cell Cycle Regulation to Drive Leukemic Transformation Graphical

Salam A. Assi, J. Allan, C. Bonifer, 2018 .

A FOXO1-induced oncogenic network defines the AML1-ETO preleukemic program.

Salam A. Assi, M. Weirauch, B. Aronow, 2017, Blood.

C/EBPα overrides epigenetic reprogramming by oncogenic transcription factors in acute myeloid leukemia.

Salam A. Assi, C. Bonifer, P. Cockerill, 2018, Blood advances.

A FOXO1-induced oncogenic network defines the AML1-ETO pre-leukemic program Running title: FOXO1 is an oncogenic mediator in AML1-ETO leukemia Scientific category: Myeloid Neoplasia

M. Weirauch, B. Aronow, Jingsong Zhang, 2017 .

Leukemic stem cells hijack lineage inappropriate signalling pathways to promote their growth

Salam A. Assi, C. Bonifer, P. Cockerill, 2023, bioRxiv.

RUNX1-ETO Depletion in t(8;21) AML Leads to C/EBPα- and AP-1-Mediated Alterations in Enhancer-Promoter Interaction

Cameron S. Osborne, Salam A. Assi, C. Osborne, 2019, Cell reports.

Subtype-specific regulatory network rewiring in acute myeloid leukemia

Salam A. Assi, P. Cauchy, L. N. Gilding, 2018, Nature Genetics.

RUNX1/ETO and mutant KIT both contribute to programming the transcriptional and chromatin landscape in t(8;21) AML.

Salam A. Assi, C. Bonifer, P. Cockerill, 2020, Experimental hematology.

Gene regulatory network analysis predicts cooperating transcription factor regulons required for FLT3-ITD+ AML growth

Salam A. Assi, C. Bonifer, P. Cockerill, 2023, bioRxiv.

Subtype-specific regulatory network rewiring in acute myeloid 1 leukemia 2

Salam A. Assi, L. N. Gilding, C. Bonifer, 2018 .

The Oncogenic Transcription Factor RUNX1/ETO Corrupts Cell Cycle Regulation to Drive Leukemic Transformation

Cameron S. Osborne, Salam A. Assi, J. Allan, 2019, Cancer cell.

A FOXO1-induced oncogenic network defines the AML1-ETO preleukemic program.

Salam A. Assi, M. Weirauch, B. Aronow, 2017, Blood.

Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia

Salam A. Assi, J. Hehir-Kwa, Z. Kingsbury, 2022, Blood.

Leukemic stem cells activate lineage inappropriate signalling pathways to promote their growth

Salam A. Assi, C. Bonifer, P. Cockerill, 2024, Nature communications.

Gene regulatory network analysis predicts cooperating transcription factor regulons required for FLT3-ITD+ AML growth

Salam A. Assi, C. Bonifer, P. Cockerill, 2023, Cell reports.